Matches in SemOpenAlex for { <https://semopenalex.org/work/W2367214440> ?p ?o ?g. }
- W2367214440 endingPage "415" @default.
- W2367214440 startingPage "401" @default.
- W2367214440 abstract "Olaparib is poorly soluble, requiring advanced drug delivery technologies for adequate bioavailability. Sixteen capsules/day are required for the approved 400 mg twice-daily dose; a tablet formulation was developed to reduce pill burden. This clinical trial evaluated the optimal dose and administration schedule of the tablet formulation. Two stages of sequentially enrolled cohorts: stage 1, pharmacokinetic properties of tablet and capsule formulations were compared in patients with advanced solid tumours; stage 2, tablet dose escalation with expansion cohorts at doses/schedules of interest in patients with solid tumours and BRCAm breast/ovarian cancers. Olaparib 200 mg tablets displayed similar Cmax,ss, but lower AUCss and Cmin,ss than 400 mg capsules. Following multiple dosing, steady-state exposure with tablets ≥300 mg matched or exceeded that of 400 mg capsules. After dose escalation, while 400 mg twice daily was the tablet maximum tolerated dose based on haematological toxicity, 65 % of patients in the randomized expansion phase eventually required dose reduction to 300 mg. Intermittent tablet administration did not significantly improve tolerability. Tumour shrinkage was similar for 300 and 400 mg tablet and 400 mg capsule cohorts. The recommended monotherapy dose of olaparib tablet for Phase III trials was 300 mg twice daily, simplifying drug administration from 16 capsules to four tablets per day. NCT00777582 (ClinicalTrials.gov)" @default.
- W2367214440 created "2016-06-24" @default.
- W2367214440 creator A5006299989 @default.
- W2367214440 creator A5009351129 @default.
- W2367214440 creator A5016736736 @default.
- W2367214440 creator A5020225283 @default.
- W2367214440 creator A5021894535 @default.
- W2367214440 creator A5028617609 @default.
- W2367214440 creator A5032324017 @default.
- W2367214440 creator A5047753094 @default.
- W2367214440 creator A5048419838 @default.
- W2367214440 creator A5050776115 @default.
- W2367214440 creator A5051430596 @default.
- W2367214440 creator A5057670922 @default.
- W2367214440 creator A5062762491 @default.
- W2367214440 creator A5064212341 @default.
- W2367214440 creator A5072708115 @default.
- W2367214440 creator A5074632224 @default.
- W2367214440 creator A5079383798 @default.
- W2367214440 creator A5081130122 @default.
- W2367214440 date "2016-05-12" @default.
- W2367214440 modified "2023-10-05" @default.
- W2367214440 title "An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib" @default.
- W2367214440 cites W1484356204 @default.
- W2367214440 cites W1970211011 @default.
- W2367214440 cites W1973268287 @default.
- W2367214440 cites W1984087886 @default.
- W2367214440 cites W2002710053 @default.
- W2367214440 cites W2009007206 @default.
- W2367214440 cites W2033816200 @default.
- W2367214440 cites W2101519297 @default.
- W2367214440 cites W2110017381 @default.
- W2367214440 cites W2110878808 @default.
- W2367214440 cites W2111437716 @default.
- W2367214440 cites W2117964602 @default.
- W2367214440 cites W2123696077 @default.
- W2367214440 cites W2130078242 @default.
- W2367214440 cites W2139248078 @default.
- W2367214440 cites W2142658272 @default.
- W2367214440 cites W2147071985 @default.
- W2367214440 cites W2156077962 @default.
- W2367214440 cites W2158742893 @default.
- W2367214440 cites W2160466424 @default.
- W2367214440 cites W2171972386 @default.
- W2367214440 cites W3093265161 @default.
- W2367214440 cites W4211147776 @default.
- W2367214440 doi "https://doi.org/10.1007/s11523-016-0435-8" @default.
- W2367214440 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27169564" @default.
- W2367214440 hasPublicationYear "2016" @default.
- W2367214440 type Work @default.
- W2367214440 sameAs 2367214440 @default.
- W2367214440 citedByCount "98" @default.
- W2367214440 countsByYear W23672144402016 @default.
- W2367214440 countsByYear W23672144402017 @default.
- W2367214440 countsByYear W23672144402018 @default.
- W2367214440 countsByYear W23672144402019 @default.
- W2367214440 countsByYear W23672144402020 @default.
- W2367214440 countsByYear W23672144402021 @default.
- W2367214440 countsByYear W23672144402022 @default.
- W2367214440 countsByYear W23672144402023 @default.
- W2367214440 crossrefType "journal-article" @default.
- W2367214440 hasAuthorship W2367214440A5006299989 @default.
- W2367214440 hasAuthorship W2367214440A5009351129 @default.
- W2367214440 hasAuthorship W2367214440A5016736736 @default.
- W2367214440 hasAuthorship W2367214440A5020225283 @default.
- W2367214440 hasAuthorship W2367214440A5021894535 @default.
- W2367214440 hasAuthorship W2367214440A5028617609 @default.
- W2367214440 hasAuthorship W2367214440A5032324017 @default.
- W2367214440 hasAuthorship W2367214440A5047753094 @default.
- W2367214440 hasAuthorship W2367214440A5048419838 @default.
- W2367214440 hasAuthorship W2367214440A5050776115 @default.
- W2367214440 hasAuthorship W2367214440A5051430596 @default.
- W2367214440 hasAuthorship W2367214440A5057670922 @default.
- W2367214440 hasAuthorship W2367214440A5062762491 @default.
- W2367214440 hasAuthorship W2367214440A5064212341 @default.
- W2367214440 hasAuthorship W2367214440A5072708115 @default.
- W2367214440 hasAuthorship W2367214440A5074632224 @default.
- W2367214440 hasAuthorship W2367214440A5079383798 @default.
- W2367214440 hasAuthorship W2367214440A5081130122 @default.
- W2367214440 hasBestOaLocation W23672144402 @default.
- W2367214440 hasConcept C104317684 @default.
- W2367214440 hasConcept C112705442 @default.
- W2367214440 hasConcept C126894567 @default.
- W2367214440 hasConcept C181389837 @default.
- W2367214440 hasConcept C182979987 @default.
- W2367214440 hasConcept C185592680 @default.
- W2367214440 hasConcept C197934379 @default.
- W2367214440 hasConcept C22979827 @default.
- W2367214440 hasConcept C2777288759 @default.
- W2367214440 hasConcept C2778375690 @default.
- W2367214440 hasConcept C2778778583 @default.
- W2367214440 hasConcept C2779962180 @default.
- W2367214440 hasConcept C55493867 @default.
- W2367214440 hasConcept C59822182 @default.
- W2367214440 hasConcept C71924100 @default.
- W2367214440 hasConcept C82381507 @default.
- W2367214440 hasConcept C86803240 @default.
- W2367214440 hasConcept C98274493 @default.